VPS9D1 抗体 (Cy5.5)
-
- 抗原 See all VPS9D1 products
- VPS9D1 (VPS9 Domain Containing 1 (VPS9D1))
- 适用
- 人, 小鼠, 大鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This VPS9D1 antibody is conjugated to Cy5.5
-
应用范围
- Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- 交叉反应
- 人, 小鼠, 大鼠
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic peptide derived from human C16orf7/ATP-BL
- 亚型
- IgG
-
-
- 应用备注
- IF(IHC-P) 1:50-200
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- 有效期
- 12 months
-
- 抗原
- VPS9D1 (VPS9 Domain Containing 1 (VPS9D1))
- 别名
- C16orf7 (VPS9D1 产品)
- 别名
- ATP-BL antibody, C16orf7 antibody, 1300018I17Rik antibody, 2410004N05Rik antibody, 5DOS1 antibody, Vsp9d1 antibody, VPS9 domain containing 1 antibody, VPS9D1 antibody, Vps9d1 antibody
- 背景
-
Synonyms: ATP BL, C16orf7, Chromosome 16 open reading frame 7, CP007_HUMAN, Protein ATP-BL, Uncharacterized protein C16orf7.
Background: Chromosome 16 encodes over 900 genes in approximately 90 million base pairs, makes up nearly 3 % of human cellular DNA and is associated with a variety of genetic disorders. The GAN gene is located on chromosome 16 and, with mutation, may lead to giant axonal neuropathy, a nervous system disorder characterized by increasing malfunction with growth. The rare disorder Rubinstein-Taybi syndrome is also associated with chromosome 16, though through the CREBBP gene which encodes a critical CREB binding protein. Signs of Rubinstein-Taybi include mental retardation and predisposition to tumor growth and white blood cell neoplasias. Crohn's disease is a gastrointestinal inflammatory condition associated with chromosome 16 through the NOD2 gene. An association with systemic lupus erythematosis and a number of other autoimmune disorders with the pericentromeric region of chromosome 16 has led to the identification of SLC5A11 as a potential autoimmune modifier.
-